# FDA Inspection 1222602 - Syntese A/S - May 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/syntese-as/cd62adcd-673f-4e89-bbe2-3aa23ad61954
Source feed: FDA_Inspections

> FDA Inspection 1222602 for Syntese A/S on May 12, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222602
- Company Name: Syntese A/S
- Inspection Date: 2023-05-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 981321 - 2016-06-17](https://www.keypedia.com/records/fda_inspections/syntese-as/9b425864-6f97-49ee-9723-e1a9bed86a5e)
- [FDA Inspection 874434 - 2014-03-20](https://www.keypedia.com/records/fda_inspections/syntese-as/9dcf04a8-4a4f-468e-9d6b-4083a445e3b1)

Company: https://www.keypedia.com/companies/syntese-as/8baba4ab-b3f1-491d-a996-2665f5d0f53c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c